These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6172879)

  • 1. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
    Ryde M; Eriksson H; Tangen O
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin.
    Vinazzer H; Haas S; Stemberger A
    Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
    Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE; Kwaan HC; Szczecinski M
    J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of a heparinoid derived from pentosan].
    Lansen J; Diner H
    Agressologie; 1983 Dec; 24(12):591-5. PubMed ID: 6199994
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.
    Campbell A; Nesheim ME; Doctor VM
    Thromb Res; 1987 Aug; 47(3):341-52. PubMed ID: 2442830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
    Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
    Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and anticoagulant properties of a new sulfated xylan: comparison with heparin and a sodium pentosan polysulfate (SP-54).
    Doctor VM; Sauls V
    Thromb Res; 1983 Jun; 30(6):573-8. PubMed ID: 6193601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 16. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
    Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the action of an acidic sulfated polysaccharide on global blood coagulation in vitro. Preliminary study in various species of mammals and in man].
    Caporiccio B; Braun M; Vignaud M; Chalet M; Teste J; Codomier L; Catayée G
    C R Seances Soc Biol Fil; 1983; 177(4):412-20. PubMed ID: 6202380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
    Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale behind the development of low molecular weight heparin derivatives.
    Hirsh J; Ofosu F; Buchanan M
    Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy.
    Forestier F; Fischer AM; Daffos F; Beguin S; Diner H
    Thromb Haemost; 1986 Dec; 56(3):247-9. PubMed ID: 2436327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.